NY-EMPIRE-STATE-REALTY
The Empire State Building (ESB), in collaboration with Disney Consumer Products and Lucasfilm, today unveiled a Star Wars™-themed, villains-inspired takeover for fans in New York City that featured a dynamic light show, immersive experiences for visitors, character appearances, and participation from actor Hayden Christensen in a morning lighting ceremony. Fans who visit ESB this month will have the opportunity to immerse themselves into the Star Wars galaxy photo opportunities which feature a range of new Star Wars consumer products through April 29.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321369670/en/
The Empire State Building Unveils Star Wars-Themed Takeover with a Dynamic Light Show, Interactive Fan Experiences, Celebrity Visit, and More (Photo: Business Wire)
"We are so pleased to unite Star Wars fans in New York City and throughout the world with this epic trip to a galaxy far, far away….,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This one-of-a-kind takeover at the ‘World’s Most Famous Building’ allows fans to come face to face with pop culture’s most iconic villains in an authentic New York City way.”
Star Wars in Lights
This evening, a dynamic light show that featured fan-favorite scenes of Star Wars villains debuted on the building’s south side façade from 8 p.m. in continued intervals until 11 p.m. The montage was synched to the iconic “The Imperial March (Darth Vader’s Theme),” and was streamed simultaneously on iHeartRadio’s Z100 New York radio station and on the iHeartRadio app.
Star Wars actor Hayden Christensen visited the Empire State Building earlier this morning to tour the world-famous Observatory Experience and flip the ceremonial switch ahead of the dynamic light show.
Step into the Scenes
The Empire State Building’s iconic Fifth Avenue Lobby windows now feature special Star Wars-themed artistry that depicts scenes of Darth Vader, Darth Maul, and stormtroopers surrounded by a range of Star Wars merchandise, in collaboration with Disney Consumer Products and Lucasfilm. The window exhibit will remain on display until April 29.
At the base of the building, visitors can also join Hasbro and Amazon for a Star Wars fan experience on March 21-22 from 1-9 p.m. and on March 23 from 10-8 p.m. The experience highlights the villains of the Star Wars galaxy and features photo opportunities with costumed characters, which include Darth Vader and stormtroopers — as well as photo backdrops that recreate iconic scenes and locations inspired by the films like the opening hallway scene from Rogue One: A Star Wars Story, the Star Destroyer bridge, and Emperor Palpatine’s throne. Guests can also pose in the blister card packaging of a Star Wars Vintage Collection figure. Additionally, attendees will be able to check out the latest Hasbro Black Series helmets or wield their favorite character’s FX Elite or Kyber Core Lightsaber™ adult and kid collectibles.
To celebrate 25 years of the LEGO® Star Wars™ collaboration, the Empire State Building features a museum-quality display of life-sized Star Wars villains like six-foot tall brick-built recreations of Darth Vader and Darth Maul on the building’s 80th Floor. Fans also have the chance to pose with a 3D LEGO® Star Wars™ mural of Luke Skywalker and other fan-favorite characters from the film series. This exclusive LEGO® Star Wars™ exhibit will remain on display in the Observatory until April 29.
Once they reach the iconic 86th Floor Observatory, fans can pose for a photo with a life-size Darth Vader-themed POP! Figure from Funko with ESB’s unmatched New York City views as a backdrop until April 29. On March 21 and 22 from 10 a.m. to 1 p.m., Dairy Farmers of America will treat guests to samples of their new TruMoo Star Wars Blue Milk – inspired by the blue milk that made its first appearance in Star Wars: A New Hope.
“The Empire Strikes Back”
The Empire State Building Observatory will host a movie screening of Star Wars: The Empire Strikes Back on the 80th Floor on March 22. Guests who purchase tickets to the exclusive movie night will receive complimentary drinks and snacks to enjoy with the movie and access to the famed 86th and 102nd Floor Observatories. Tickets can be purchased here.
The Empire State Building Observatory recently underwent a $165 million reimagination that included the addition of a dedicated visitor entrance, an immersive museum with nine galleries, brand-new, bespoke Observatory Host uniforms, and a new 102nd Floor Observatory with unmatched views. The reimagined Observatory Experience has been voted the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years.
Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.
Hi-res imagery and video can be found here. More information about the Empire State Building can be found online.
Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & TM Lucasfilm Ltd.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240321369670/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom